Prognostic factors after complete resection of pN2 non-small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 146, Issue 4, 2013, Pages 788-795

  Sonobe, Makoto ^a   Date, Hiroshi ^a   Wada, Hiromi ^a,b   Okubo, Kenichi ^a,c   Hamakawa, Hiroshi ^a,d   Teramukai, Satoshi ^a   Matsumura, Akihide ^e   Nakagawa, Tatuo ^f   Sumitomo, Shin Ichi ^g   Miyamoto, Yoshihiro ^h   Okumura, Norihito ⁱ   Takeo, Sadanori ^j   Kawakami, Kenzo ^k   Aoki, Minoru ^l   Kosaka, Shinji ^m  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b Karasuma Wada Clinic   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY HOSPITAL   (Japan)

^d KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

^f TENRI HOSPITAL   (Japan)

^g JAPANESE RED CROSS WAKAYAMA MEDICAL CENTER   (Japan)

^h NATIONAL HOSPITAL ORGANIZATION HIMEJI MEDICAL CENTER   (Japan)

ⁱ KURASHIKI CENTRAL HOSPITAL   (Japan)

^j NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^k SHIGA MEDICAL CENTER FOR ADULTS   (Japan)

^l NISHI KOBE MEDICAL CENTER   (Japan)

^m SHIMANE PREFECTURAL CENTRAL HOSPITAL   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; FLUOROURACIL; GEMCITABINE; MITOMYCIN; PACLITAXEL; UFT; VINDESINE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LOBECTOMY; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

10; 10.4; C; CLINICAL; DFS; DISEASE-FREE SURVIVAL; EASTERN COOPERATIVE ONCOLOGY GROUP; ECOG; EGFR; EPIDERMAL GROWTH FACTOR RECEPTOR; HAZARD RATIO; HR; INTRAVENOUS CHEMOTHERAPY; IV-CT; JAPAN-MULTINATIONAL TRIAL ORGANIZATION; JMTO; NON-SMALL CELL LUNG CANCER; NSCLC; OPERATIVE SURVIVAL; OS; P; PATHOLOGIC; PERFORMANCE STATUS; PS; TEGAFUR-URACIL; UFT;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PNEUMONECTOMY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84884418737     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2013.04.043     Document Type: Article

References (25)

1. R. Sakata, Y. Fujii, and H. Kuwano Thoracic and cardiovascular surgery in Japan during 2009. Annual report by The Japanese Association for Thoracic Surgery Gen Thorac Cardiovasc Surg 59 2011 636 667
2. J.P. Pignon, H. Tribodet, G.V. Scagliotti, J.Y. Douillard, F.A. Shepherd, and R.J. Stephens Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group J Clin Oncol 26 2008 3552 3559
3. H. Wada, S. Hitomi, and T. Teramatsu Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery J Clin Oncol 14 1996 1048 1054 (Pubitemid 26105508)
4. H. Tada, R. Tsuchiya, Y. Ichinose, T. Koike, N. Nishizawa, and K. Nagai A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG 9304) Lung Cancer 43 2004 167 173 (Pubitemid 38114745)
5. Y. Ichinose, H. Kato, T. Koike, R. Tsuchiya, T. Fujisawa, and N. Shimizu Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials Lung Cancer 34 2001 29 36 (Pubitemid 32824120)
6. T. Nakagiri, N. Sawabata, S. Funaki, M. Inoue, Y. Kadota, and Y. Shintani Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer Interact Cardiovasc Thorac Surg 12 2011 733 738
7. K. Yokoi Record for lung cancer surgery Kanehara shuppan The Japan Lung Cancer Society General rule for clinical and pathological record of lung cancer 7th ed. 2010 47 61
8. C.F. Mountain Revisions in the international system for staging lung cancer Chest 111 1997 1710 1717 (Pubitemid 27260107)
9. T.V. Colby, M. Noguchi, C. Henshke, M.F. Vazquez, K. Geisinger, and T. Yokose Adenocarcinoma W.D. Travis, E. Brambilla, H.K. Muller-Hermelink, C.C. Harris, World Health Organization classification of tumours: pathology and genetics of tumours of the lung, pleura, thymus and heart 2004 IARC Press Lyon 35 44
10. P. Goldstraw, J. Crowley, K. Chansky, D.J. Giroux, P.A. Groome, R. Rami-Porta International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours J Thorac Oncol 8 2007 706 714 (Pubitemid 47357522)
11. Non-Small Cell Lung Cancer Collaborative Group Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer Cochrane Database Syst Rev 12 2010 CD007309
12. T. Kosaka, Y. Yatabe, H. Endoh, H. Kuwano, T. Takahashi, and T. Mitsudomi Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications Cancer Res 64 2004 8919 8923 (Pubitemid 39665498)
13. H. Shigematsu, L. Lin, T. Takahashi, M. Nomura, M. Suzuki, and I.I. Wistuba Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers J Natl Cancer Inst 97 2005 339 346 (Pubitemid 40425952)
14. M. Sonobe, M. Kobayashi, M. Ishikawa, R. Kikuchi, E. Nakayama, and T. Takahashi Impact of KRAS and EGFR Gene Mutations on Recurrence and Survival in Patients with Surgically Resected Lung Adenocarcinomas Ann Surg Oncol 19 Suppl 3 2012 S347 S354
15. Y. Ohta, Y. Shimizu, H. Minato, I. Matsumoto, M. Oda, and G. Watanabe Results of initial operations in non-small cell lung cancer patients with single-level N2 disease Ann Thorac Surg 81 2006 427 433 (Pubitemid 43120530)
16. M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka Prognosis of completely resected pN2 non-small cell lung carcinomas: what is the significant node that affects survival? J Thorac Cardiovasc Surg 118 1999 270 275 (Pubitemid 29360329)
17. H. Uehara, Y. Sakao, M. Mun, K. Nakagawa, M. Nishio, and Y. Ishikawa Prognostic value and significance of subcarinal and superior mediastinal lymph node metastasis in lower lobe tumours Eur J Cardiothorac Surg 38 2010 498 502
18. M. Inoue, N. Sawabata, S. Takeda, M. Ohta, Y. Ohno, and H. Maeda Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe J Thorac Cardiovasc Surg 127 2004 1100 1106 (Pubitemid 38451944)
19. M. Riquet, J. Assouad, P. Bagan, C. Foucault, F. Le Pimpec Barthes, and A. Dujon Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis Ann Thorac Surg 79 2005 225 233 (Pubitemid 40037476)
20. J.G. Lee, C.Y. Lee, I.K. Park, D.J. Kim, S.H. Cho, and K.D. Kim The prognostic significance of multiple station N2 in patients with surgically resected stage IIIA N2 non-small cell lung cancer J Korean Med Sci 23 2008 604 608
21. P. Misthos, E. Sepsas, J. Kokotsakis, I. Skottis, and A. Lioulias The significance of one-station N2 disease in the prognosis of patients with non-small-cell lung cancer Ann Thorac Surg 86 2008 1626 1631
22. S. Wei, H. Asamura, R. Kawachi, H. Sakurai, and S. Watanabe Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification? J Thorac Oncol 6 2011 310 318
23. G. Friedel, V. Steger, T. Kyriss, J. Zoller, and H. Toomes Prognosis in N2 NSCLC Lung Cancer 45 2004 545 553
24. J.P. van Meerbeeck, G.W. Kramer, P.E. Van Schil, C. Legrand, E.F. Smit, F. Schramel European Organisation for Research and Treatment of Cancer-Lung Cancer Group Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer J Natl Cancer Inst 99 2007 442 450 (Pubitemid 47073567)
25. K.S. Albain, R.S. Swann, V.W. Rusch, A.T. Turrisi 3rd, F.A. Shepherd, and C. Smith Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial Lancet 374 2009 379 386